A combination hairstyling and sunscreen composition. The composition is configured to allow a user to style and set hair while providing protection from ultra-violet rays that can damage skin. A hairstyling component allows users to style their hair and a sunscreen component simultaneously protects the scalp from sun damage. The composition may be formulated in a gel, liquid, or spray consistency for application. Thinning hair is easily styled while the scalp is protected from sunburn without leaving an oily residue.

The invention relates to a composition for dyeing human keratin fibers, preferably the hair, comprising:—one or more anthraquinone cationic direct dyes,—one or more polyols,—one or more anionic surfactants, and—one or more nonionic polysaccharides.

The present invention relates to a process for dyeing keratin fibers using a) one or more direct dyes and b) one or more particular saccharinate salts.

A method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors are described. The composition has a retinoic acid precursor and a resorcinol to impede oxidation of the precursor in situ in the composition.

The present invention relates to a polymer comprising: (a) from 90 mol-% to 99.9 mol-%, of repeating units according to Formula (1) wherein at least 10 wt.-% of the repeating units according to Formula (1) comprise from 28 wt.-% to 100 wt.-% bio-based carbon content, relative to the total mass of carbon in the repeating unit according to Formula (1), measured according to standard ASTM D6866-12, Method B; ##STR00001##
and (b) from 0.01 mol-% to 10 mol-% of crosslinking or branching units, wherein the crosslinking or branching units result from the incorporation of a monomer comprising at least two olefinically unsaturated double bonds.

The present invention relation to an oral care composition comprising a cannabinoid and at least one pharmaceutical active component is provided in which the at least one pharmaceutical active component improves oral health beyond benefits provided by the at least one cannabinoid alone. The at least one pharmaceutical active component can be Manuka honey. The oral care composition can be used in an oral care product for whitening or bleaching teeth.

This invention relates to a hair care composition that contains at least one hair care ingredient and at least one polymeric colorant.

The present invention relates to a stable powder composition comprising hair direct dyes which is used for dyeing hair after mixing with one or more aqueous compositions. The composition comprises one or more direct dyes selected from HC Red 18, HC Blue 18, and HC Yellow 16, one or more alkanolamine as alkalizing agent, an organic and/or an inorganic pulverulent excipient.

Provided are a cosmetic composition, a food composition, a pharmaceutical composition, and an over-the-counter (OTC) composition for skin elasticity enhancement and skin wrinkle reduction, a composition for promoting differentiation or proliferation of human adipose-derived stem cells, and a method of enhancing skin elasticity including administering the compositions to an individual other than a human, each composition including at least one substance selected from the group consisting of formononetin, emodin, artepillin C, carnosic acid, palmitamide, sodium guaiazulene sulfonate, caffeic acid, acetyl mandelic acid, laccaic acid, ubiquinone, hydroxycinnamic acid, xanthophyll, raspberry ketone, gallic acid, terpineol, sodium mannose phosphate, tropolone, glycyrrhetinic acid, lanosterol, sodium riboflavin phosphate, menadione, thioctic acid, lactoflavin, onion extract, rice bran extract, bamboo extract, carrot extract, Hibiscus extract, Magnoliae cortex extract, Aloe vera extract, and fractions of the extracts as an active ingredient.

A method of identifying or evaluating synergistic combinations of actives such as skin-care actives that improve the metabolism of a cell and provides an advantage over using the actives alone. The method includes contacting cells with test agents, alone and in combination, and determining a response of the cells to the test agent(s), wherein the response corresponds to a change in a metabolic indicator associated with glycolysis and a change in a metabolic indicator associated with oxidative phosphylation.